These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
331 related items for PubMed ID: 16645507
1. Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy. Hartman K, Verweel G, de Groot R, Hartwig NG. Pediatr Infect Dis J; 2006 May; 25(5):427-31. PubMed ID: 16645507 [Abstract] [Full Text] [Related]
2. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population. Hansen AB, Lindegaard B, Obel N, Andersen O, Nielsen H, Gerstoft J. HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291 [Abstract] [Full Text] [Related]
3. Impact on weight and height with the use of HAART in HIV-infected children. Guillén S, Ramos JT, Resino R, Bellón JM, Muñoz MA. Pediatr Infect Dis J; 2007 Apr; 26(4):334-8. PubMed ID: 17414398 [Abstract] [Full Text] [Related]
8. High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda. van Griensven J, De Naeyer L, Mushi T, Ubarijoro S, Gashumba D, Gazille C, Zachariah R. Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):793-8. PubMed ID: 17467756 [Abstract] [Full Text] [Related]
10. Persistence of lipoatrophy after a four-year long interruption of antiretroviral therapy for HIV1 infection: case report. Parruti G, Toro GM. BMC Infect Dis; 2005 Oct 03; 5():80. PubMed ID: 16202141 [Abstract] [Full Text] [Related]
15. Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial. Sutinen J, Walker UA, Sevastianova K, Klinker H, Häkkinen AM, Ristola M, Yki-Järvinen H. Antivir Ther; 2007 Jun 03; 12(1):97-105. PubMed ID: 17503753 [Abstract] [Full Text] [Related]
16. Body shape and composition in HIV-infected women: an urban cohort. Karmon SL, Moore RD, Dobs AS, Keruly J, Barnett S, Cofrancesco J. HIV Med; 2005 Jul 03; 6(4):245-52. PubMed ID: 16011529 [Abstract] [Full Text] [Related]
17. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy. Sevastianova K, Sutinen J, Kannisto K, Hamsten A, Ristola M, Yki-Järvinen H. Am J Physiol Endocrinol Metab; 2008 Jul 03; 295(1):E85-91. PubMed ID: 18430964 [Abstract] [Full Text] [Related]
18. Mitochondrial DNA haplogroups and highly active antiretroviral therapy-related lipodystrophy. Nasi M, Guaraldi G, Orlando G, Durante C, Pinti M, Nemes E, Nardini G, Passarino G, Cocchi M, Esposito R, Mussini C, Cossarizza A. Clin Infect Dis; 2008 Oct 01; 47(7):962-8. PubMed ID: 18752438 [Abstract] [Full Text] [Related]
20. Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy. Calmy A, Carey D, Mallon PW, Wand H, Law M, Cooper DA, Carr A, INITIO Trial International Co-ordinating Committee, HAMA study coordination team. HIV Med; 2008 Feb 01; 9(2):101-10. PubMed ID: 18257772 [Abstract] [Full Text] [Related] Page: [Next] [New Search]